{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-028739","form_type":"8-K","ticker":"VTRS","cik":"0001792044","company_name":"Viatris Inc","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.007787+00:00","generated_at":"2026-05-17T20:54:07.532913+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Viatris appoints ex-PPD CEO David Simmons to board; board expands to 15","bullets":["David Simmons appointed independent director effective August 4, 2025; board size increased from 14 to 15.","Simmons was Chairman/CEO of PPD (led to $17.4B sale to Thermo Fisher), 15+ years at Pfizer, CEO of Caliber Holdings.","No related-party transactions or arrangements per Item 404(a) of Regulation S-K.","Committee assignments pending; compensation consistent with other non-employee directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-028739","json":"https://secwatch.observer/filing/0001140361-25-028739.json","markdown":"https://secwatch.observer/filing/0001140361-25-028739.md","text":"https://secwatch.observer/filing/0001140361-25-028739.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1792044/000114036125028739/0001140361-25-028739-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1792044/000114036125028739/ef20053146_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:54:07.532913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}